- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BEAM
Recent news which mentions BEAM
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
From InvestorPlace
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
October 18, 2023
From Motley Fool
2 Cathie Wood Stocks I'm Bullish On
October 05, 2023
From Motley Fool
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
October 03, 2023
From Motley Fool
Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems?
October 02, 2023
From Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
September 29, 2023
From Motley Fool
Cathie Wood's Ark Invest Tweaks Portfolio, Sells $1.8M Worth Of DraftKings Shares
September 28, 2023
From Benzinga
2 Magnificent Growth Stocks to Buy On the Dip
September 27, 2023
From Motley Fool
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
September 22, 2023
From Motley Fool
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
September 19, 2023
From Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
September 17, 2023
From Motley Fool
From Motley Fool
Cathie Wood's Buying These 3 Stocks Hand Over Fist
September 08, 2023
From Motley Fool
Cathie Wood's Ark Invest Keeps Shedding Shopify Nvidia Shares, Loads Up On Spotify Stock
September 05, 2023
From Benzinga
Beam Therapeutics' Role In Gene-Editing 2.0 Revolution: First U.S. Patient Treated With Base-Edited Cell Therapy
September 05, 2023
Tickers
BEAM
From Benzinga
Why Is Apellis Pharmaceuticals Stock Trading Lower Today?
August 29, 2023
From Benzinga
From Motley Fool
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
August 19, 2023
From Motley Fool
Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company
August 15, 2023
From Benzinga
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
August 14, 2023
From Benzinga
Credit Suisse Maintains Neutral Rating for Beam Therapeutics: Here's What You Need To Know
August 09, 2023
Tickers
BEAM
From Benzinga
2 Supercharged Growth Stocks That Could Make You Richer
July 15, 2023
From Motley Fool
3 Pharma Stocks That AI is Loving in July
July 13, 2023
From InvestorPlace
From Motley Fool
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.